DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Acupuncture for Pain Relief During Induced Labour in Nulliparae

Not Applicable

Completed

Conditions: Pain

Interventions: Procedure: acupuncture

First Posted Date: 2010-07-19

Last Posted Date: 2019-04-30

Lead Sponsor: University of Oxford

Target Recruit Count: 105

Registration Number: NCT01165099

Locations: 🇬🇧
John Radcliffe Hospital, Oxford, United Kingdom

Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults

Phase 1

Completed

Conditions: HIV-1 Infections

Interventions: Other: Placebo
Biological: ChAdV63.HIVconsv low dose.
Biological: ChAdV63.HIVconsv high dose.
Biological: pSG2.HIVconsv
Biological: MVA.HIVconsv

First Posted Date: 2010-06-28

Last Posted Date: 2014-04-30

Lead Sponsor: University of Oxford

Target Recruit Count: 32

Registration Number: NCT01151319

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxon, United Kingdom

Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: AdCh63 MSP1, MVA MSP1, challenge
Biological: AdCh63 AMA1, MVA AMA1, challenge
Biological: AdCh63 AMA1, AdCh63 MSP1, MVA AMA1, MVA MSP1, challenge
Biological: AdCh63 MSP1, AdCh63 ME-TRAP, MVA MSP1, MVA ME-TRAP, challenge
Biological: Sporozoite challenge

First Posted Date: 2010-06-11

Last Posted Date: 2011-03-28

Lead Sponsor: University of Oxford

Target Recruit Count: 52

Registration Number: NCT01142765

Locations: 🇬🇧
Hospital for Tropical Diseases Mortimer Market, London, United Kingdom
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom
🇬🇧
Wellcome Trust Clinical Research Facility, University of Southampton, Southampton, United Kingdom

Can we Reduce the Number of Vaccine Injections for Children?

Phase 4

Completed

Conditions: Invasive Meningococcal Disease

Interventions: Biological: Glyco-conjugate Neisseria meningitidis serogroup C (MenC) vaccine
Biological: Routine schedule immunisations except monovalent MenC vaccine

First Posted Date: 2010-05-24

Last Posted Date: 2015-11-09

Lead Sponsor: University of Oxford

Target Recruit Count: 404

Registration Number: NCT01129518

Locations: 🇬🇧
Oxford Vaccine Group, Oxford, United Kingdom

Understanding the Persistence of Immunity After MenC Vaccines

Completed

Conditions: Healthy

Interventions: Procedure: Venepuncture

First Posted Date: 2010-05-20

Last Posted Date: 2013-05-09

Lead Sponsor: University of Oxford

Target Recruit Count: 240

Registration Number: NCT01126996

Locations: 🇬🇧
Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom

Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy

Phase 2

Completed

Conditions: Kidney Transplantation

Interventions: Drug: Alemtuzumab
Drug: Basiliximab
Drug: Tacrolimus
Drug: Sirolimus

First Posted Date: 2010-05-10

Last Posted Date: 2020-04-02

Lead Sponsor: University of Oxford

Target Recruit Count: 852

Registration Number: NCT01120028

Locations: 🇬🇧
Oxford Radcliffe Hospitals NHS Trust, Oxford, Oxon, United Kingdom
🇬🇧
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
🇬🇧
University Hospitals Coventry & Warwickshire, Coventry, United Kingdom

and more 17 locations

Factors Affecting Medical Student Learning in Simulation Scenarios

Not Applicable

Completed

Conditions: Learning

Interventions: Other: Simulation scenario

First Posted Date: 2010-05-05

Last Posted Date: 2012-06-19

Lead Sponsor: University of Oxford

Target Recruit Count: 76

Registration Number: NCT01117467

Locations: 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom

Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria

Completed

Conditions: Falciparum Malaria

Interventions: Drug: artesunate plus sulfadoxine-pyrimethamine (AS+SP)

First Posted Date: 2010-05-04

Last Posted Date: 2012-07-12

Lead Sponsor: University of Oxford

Target Recruit Count: 100

Registration Number: NCT01115439

Locations: 🇦🇫
Provincial Malaria Control Centers (MRC), Taloqan, Afghanistan

Neural Responses and Dysphoria: Modulation by a Pharmacological Probe

Phase 4

Completed

Conditions: Dysphoria

Interventions: Drug: Placebo
Drug: Escitalopram

First Posted Date: 2010-04-12

Last Posted Date: 2011-06-07

Lead Sponsor: University of Oxford

Target Recruit Count: 160

Registration Number: NCT01101685

Locations: 🇬🇧
Department of Psychiatry, Oxford, United Kingdom

13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study

Phase 4

Completed

Conditions: Pneumococcal Disease

Interventions: Biological: PCV13

First Posted Date: 2010-03-30

Last Posted Date: 2011-03-22

Lead Sponsor: University of Oxford

Target Recruit Count: 100

Registration Number: NCT01095471

Locations: 🇬🇧
St George's Vaccine Institute, University of London, London, United Kingdom
🇬🇧
Bristol Children's Vaccine Centre, University of Bristol, Bristol, United Kingdom
🇬🇧
Wellcome Trust Clinical Research Facility, University of Southampton, Southampton, United Kingdom

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy